有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | (2S,3Z)-3-cyclopropyl-2-ethylsulfonyl-3-hydroxyiminopropan-1-ol | —— | C8H15NO4S |
|
—— | (1R,2R)-1-cyclopropyl-2-methylsulfonylpropan-1-amine | —— | C7H15NO2S |
|
—— | (3R,4R)-4-ethylsulfonyl-2,2-dimethylpentan-3-amine | —— | C9H21NO2S |
|
—— | (3S,4S)-4-ethylsulfonyl-2,2-dimethylpentan-3-amine | —— | C9H21NO2S |
|
—— | (1S,2S)-1-cyclopropyl-2-methylsulfonylpropan-1-amine | —— | C7H15NO2S |
|
—— | (3R,4R)-2,2-dimethyl-4-methylsulfonylpentan-3-amine | —— | C8H19NO2S |
|
—— | (2S,3E)-2-ethylsulfonyl-3-hydroxyiminobutan-1-ol | —— | C6H13NO4S |
|
—— | (2R,3Z)-3-cyclopropyl-3-hydroxyimino-2-methylsulfonylpropan-1-ol | —— | C7H13NO4S |
|
—— | (2S,3Z)-3-hydroxyimino-4,4-dimethyl-2-methylsulfonylpentan-1-ol | —— | C8H17NO4S |
|
—— | (NZ)-N-[(3R)-3-ethylsulfonylpentan-2-ylidene]hydroxylamine | —— | C7H15NO3S |
|
—— | (NZ)-N-[(4S)-4-ethylsulfonyl-2,2-dimethylhexan-3-ylidene]hydroxylamine | —— | C10H21NO3S |
|
—— | (2S,3E)-2-ethylsulfonyl-3-hydroxyimino-4,4-dimethylpentan-1-ol | —— | C9H19NO4S |
|
—— | (2R,3Z)-3-hydroxyimino-2-methylsulfonylbutan-1-ol | —— | C5H11NO4S |
|
—— | (NZ)-N-[(2R)-1-cyclopropyl-2-ethylsulfonylpropylidene]hydroxylamine | —— | C8H15NO3S |
|
—— | (NZ)-N-(1-ethylsulfonylpropan-2-ylidene)hydroxylamine | —— | C5H11NO3S |
|
—— | (NZ)-N-[(3R)-3-ethylsulfonylbutan-2-ylidene]hydroxylamine | —— | C6H13NO3S |
|
—— | (2S,3Z)-3-hydroxyimino-2-methylsulfonylbutan-1-ol | —— | C5H11NO4S |
|
—— | (NZ)-N-[(2R)-1-cyclopropyl-2-ethylsulfonylbutylidene]hydroxylamine | —— | C9H17NO3S |
|
—— | (NZ)-N-[(2S)-1-cyclopropyl-2-ethylsulfonylpropylidene]hydroxylamine | —— | C8H15NO3S |
|
—— | (NZ)-N-[(2R)-1-cyclopropyl-2-methylsulfonylpropylidene]hydroxylamine | —— | C7H13NO3S |
|
—— | (2S,3Z)-3-cyclopropyl-3-hydroxyimino-2-methylsulfonylpropan-1-ol | —— | C7H13NO4S |
|
—— | (NZ)-N-[(4R)-2,2-dimethyl-4-methylsulfonylpentan-3-ylidene]hydroxylamine | —— | C8H17NO3S |
|
—— | (NZ)-N-[(4R)-2,2-dimethyl-4-methylsulfonylhexan-3-ylidene]hydroxylamine | —— | C9H19NO3S |
|
—— | (NZ)-N-[(2S)-1-cyclopropyl-2-ethylsulfonylbutylidene]hydroxylamine | —— | C9H17NO3S |
|
—— | N-[(1S)-1-(2,4-difluorophenyl)ethyl]-3-(4-fluorophenyl)sulfanylpropanamide | —— | C17H16F3NOS |
|
—— | (NZ)-N-[(3S)-3-ethylsulfonylbutan-2-ylidene]hydroxylamine | —— | C6H13NO3S |
|
—— | (NZ)-N-(1-ethylsulfonyl-3,3-dimethylbutan-2-ylidene)hydroxylamine | —— | C8H17NO3S |
|
—— | (NZ)-N-[(4S)-2,2-dimethyl-4-methylsulfonylhexan-3-ylidene]hydroxylamine | —— | C9H19NO3S |
|
—— | N-[(1S)-1-(2,4-difluorophenyl)ethyl]-2-phenylsulfanylacetamide | —— | C16H15F2NOS |
|
—— | (NZ)-N-[(2S)-1-cyclopropyl-2-methylsulfonylpropylidene]hydroxylamine | —— | C7H13NO3S |
|
—— | (NZ)-N-[(4S)-4-ethylsulfonyl-2,2-dimethylpentan-3-ylidene]hydroxylamine | —— | C9H19NO3S |
|
—— | (NZ)-N-[(2R)-1-cyclopropyl-2-methylsulfonylbutylidene]hydroxylamine | —— | C8H15NO3S |
|
—— | (NE)-N-(1-cyclopropyl-2-methylsulfonylethylidene)hydroxylamine | —— | C6H11NO3S |
|
—— | (NZ)-N-[(4S)-2,2-dimethyl-4-methylsulfonylpentan-3-ylidene]hydroxylamine | —— | C8H17NO3S |
|
—— | (NZ)-N-[(3S)-3-methylsulfonylpentan-2-ylidene]hydroxylamine | —— | C6H13NO3S |
|
—— | (2S)-N-[2-(4-fluorophenyl)ethyl]-2-[[5-(3-methylanilino)-1,3,4-thiadiazol-2-yl]sulfanyl]propanamide | —— | C20H21FN4OS2 |
|
—— | 2-[[4-ethyl-5-(furan-2-yl)-1,2,4-triazol-3-yl]sulfanyl]-N-[(1S)-1-phenylethyl]acetamide | —— | C18H20N4O2S |
|
—— | 2-[[4-ethyl-5-(furan-2-yl)-1,2,4-triazol-3-yl]sulfanyl]-N-[(1R)-1-phenylethyl]acetamide | —— | C18H20N4O2S |
|
—— | (2R,3Z)-3-hydroxyimino-4,4-dimethyl-2-methylsulfonylpentan-1-ol | —— | C8H17NO4S |
|
—— | (NZ)-N-[(3R)-3-methylsulfonylpentan-2-ylidene]hydroxylamine | —— | C6H13NO3S |
|
—— | (NZ)-N-[(2S)-1-cyclopropyl-2-methylsulfonylbutylidene]hydroxylamine | —— | C8H15NO3S |
|
—— | N-methyl-2-[[5-(3-methylanilino)-1,3,4-thiadiazol-2-yl]sulfanyl]-N-(thiophen-2-ylmethyl)acetamide | —— | C17H18N4OS3 |
|
—— | 2-[[5-(3-methylanilino)-1,3,4-thiadiazol-2-yl]sulfanyl]-N-[(1S)-1-thiophen-2-ylethyl]acetamide | —— | C17H18N4OS3 |
|
—— | (2R)-N-[(2R)-2-cyano-3-methylbutan-2-yl]-2-[[5-(3-methylanilino)-1,3,4-thiadiazol-2-yl]sulfanyl]propanamide | —— | C18H23N5OS2 |
|
—— | (2R)-1-(4-ethylpiperazin-1-yl)-2-[[5-(3-methylanilino)-1,3,4-thiadiazol-2-yl]sulfanyl]propan-1-one | —— | C18H25N5OS2 |
|
—— | 3-(4-chlorophenyl)sulfanyl-N-[(1R)-1-(2,4-difluorophenyl)ethyl]propanamide | —— | C17H16ClF2NOS |
|
—— | 1-[[2-(4-Bromophenyl)sulfanylacetyl]amino]-3-pentylthiourea | —— | C14H20BrN3OS2 |
|
—— | (1R,2R)-N'-hydroxy-2-methyl-1-methylsulfonylcyclopropane-1-carboximidamide | —— | C6H12N2O3S |
|
—— | (NE)-N-(1-cyclopropyl-2-ethylsulfonylethylidene)hydroxylamine | —— | C7H13NO3S |
|
—— | N-[(1S)-1-(2-bromophenyl)ethyl]-3-(4-fluorophenyl)sulfanylpropanamide | —— | C17H17BrFNOS |
|